Moderna Book Value Per Share Growth & History (MRNA)
Moderna's book value per share was $21.95 for fiscal 2025.
View full Moderna company overviewModerna annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $21.95 | -$6.29 | −22.26% |
| 2024 | 2024-12-31 | $28.24 | -$8.03 | −22.13% |
| 2023 | 2023-12-31 | $36.27 | -$13.40 | −26.98% |
| 2022 | 2022-12-31 | $49.67 | $14.57 | +41.51% |
| 2021 | 2021-12-31 | $35.10 | $28.68 | +446.84% |
| 2020 | 2020-12-31 | $6.42 | $2.93 | +83.84% |
| 2019 | 2019-12-31 | $3.49 | -$1.16 | −24.97% |
| 2018 | 2018-12-31 | $4.65 | $13.11 | — |
| 2017 | 2017-12-31 | -$8.46 | -$2.94 | — |
| 2016 | 2016-12-31 | -$5.51 | — | — |
Moderna quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $16.94 | -$7.22 | −29.87% |
| Q1 2026 | 2026-03-31 | $18.66 | -$7.35 | −28.26% |
| Q4 2025 | 2025-12-31 | $21.95 | -$6.29 | −22.26% |
| Q3 2025 | 2025-09-30 | $23.86 | -$7.12 | −22.97% |
| Q2 2025 | 2025-06-30 | $24.16 | -$6.34 | −20.78% |
| Q1 2025 | 2025-03-31 | $26.01 | -$7.45 | −22.28% |
| Q4 2024 | 2024-12-31 | $28.24 | -$8.03 | −22.13% |
| Q3 2024 | 2024-09-30 | $30.98 | -$4.34 | −12.28% |
| Q2 2024 | 2024-06-30 | $30.50 | -$13.99 | −31.44% |
| Q1 2024 | 2024-03-31 | $33.46 | -$15.66 | −31.87% |
| Q4 2023 | 2023-12-31 | $36.27 | -$13.40 | −26.98% |
| Q3 2023 | 2023-09-30 | $35.31 | -$11.18 | −24.04% |
| Q2 2023 | 2023-06-30 | $44.49 | -$1.39 | −3.04% |
| Q1 2023 | 2023-03-31 | $49.12 | $6.43 | +15.07% |
| Q4 2022 | 2022-12-31 | $49.67 | $14.57 | +41.51% |
| Q3 2022 | 2022-09-30 | $46.49 | $21.49 | +85.98% |
| Q2 2022 | 2022-06-30 | $45.88 | $29.24 | +175.80% |
| Q1 2022 | 2022-03-31 | $42.69 | $33.12 | +346.01% |
| Q4 2021 | 2021-12-31 | $35.10 | $28.68 | +446.84% |
| Q3 2021 | 2021-09-30 | $25.00 | $18.02 | +258.11% |
| Q2 2021 | 2021-06-30 | $16.64 | $9.14 | +122.00% |
| Q1 2021 | 2021-03-31 | $9.57 | $5.14 | +115.86% |
| Q4 2020 | 2020-12-31 | $6.42 | $2.93 | +83.84% |
| Q3 2020 | 2020-09-30 | $6.98 | $3.23 | +85.95% |
| Q2 2020 | 2020-06-30 | $7.49 | $3.45 | +85.21% |
| Q1 2020 | 2020-03-31 | $4.43 | $0.05 | +1.09% |
| Q4 2019 | 2019-12-31 | $3.49 | -$1.16 | −24.97% |
| Q3 2019 | 2019-09-30 | $3.75 | — | — |
| Q2 2019 | 2019-06-30 | $4.05 | — | — |
| Q1 2019 | 2019-03-31 | $4.39 | — | — |
| Q4 2018 | 2018-12-31 | $4.65 | $13.11 | — |
| Q4 2017 | 2017-12-31 | -$8.46 | — | — |
Moderna book value per share trends
Over the last five fiscal years, Moderna's book value per share increased from $6.42 to $21.95, a change of $15.54. The latest reported quarter, Q2 2026, shows $16.94.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Moderna source filings ↗